New program aims to ease Parents' grief after devastating prenatal diagnosis
NCT ID NCT06456034
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tests a new perinatal palliative care program for parents who receive a life-limiting diagnosis for their unborn or newborn baby. The program includes a dedicated care team, specialized training, and structured support. Researchers will enroll 20 parents and their healthcare providers to see if the program is feasible and helpful, measuring pain, grief, and satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Perinatal palliative care program (behavioral intervention)
- What this could lead to
- If it works, this could lead to a standardized way to provide emotional and practical support to parents and healthcare providers during a very difficult time.
- What could go wrong
- This is a very small pilot study (20 participants) testing feasibility, not effectiveness. The results may not apply to all hospitals or families.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIFE-LIMITING FETAL DIAGNOSIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UZ Brussels
RECRUITINGBrussels, 1090, Belgium
-
UZ Gent
NOT_YET_RECRUITINGGhent, 9000, Belgium